UPBEAT-UK: Case Management for depression and coronary heart disease

Conditions

Coronary heart disease/comorbid depression Circulatory System Other acute ischaemic heart diseases

André Tylee, Elizabeth Barley, Paul Walters, Evanthia Achilla, Rohan Borschmann et al. (16 authors)

Programme Grants for Applied Research2016-05-0111 citations

UPBEAT-UK: a programme of research into the relationship between coronary heart disease and depression in primary care patients

Tylee A, Barley EA, Walters P, Achilla E, Borschmann R, Leese M, McCrone P, Palacios J, Smith A, Simmonds R, Rose D, Murray J, van Marwijk H, Williams P, Mann A, on behalf of the UPBEAT-UK team.

2016-05-011 citations

10.1186/1471-2296-12-38

The UPBEAT Nurse-Delivered Personalized Care Intervention for People with Coronary Heart Disease Who Report Current Chest Pain and Depression: A Randomised Controlled Pilot Study

Elizabeth Barley, Paul Walters, Mark Haddad, Rachel Phillips, Evanthia Achilla et al. (9 authors)

PLoS ONE2014-06-0541 citations

10.1371/journal.pone.0098704

A pilot randomised controlled trial of personalised care for depressed patients with symptomatic coronary heart disease in South London general practices: the UPBEAT-UK RCT protocol and recruitment.

Tylee A, Haddad M, Barley E, Ashworth M, Brown J, Chambers J, Farmer A, Fortune Z, Lawton R, Leese M, Mann A, McCrone P, Murray J, Pariante C, Phillips R, Rose D, Rowlands G, Sabes-Figuera R, Smith A, Walters P.

2012-06-0611 citations

10.1186/1471-244x-12-58

Interventions

Experimental intervention (usual care plus case management): The intervention will be case management delivered by two clinically qualified researchers (a community psychiatric nurse and a health psyc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Practices: 1. Keep a register of patients with CHD for the Quality and Outcomes Framework (QOF) 2. Willing to liaise over patients in the case management arm when necessary Participants: 1. Symptomatic CHD as scored on the modified Rose Angina Questionnaire 2. Score greater than 9 on the Hospital Anxiety and Depression Scale (HADS) 3. Aged 16 years or over, either sex

Exclusion criteria

Exclusion criteria: Patients: 1. Temporary registrations 2. Actively suicidal or experiencing psychotic depression as evidenced by delusions and/or hallucinations 3. Under the care of secondary care mental health teams 4. Cannot speak English 5. Currently in hospital for treatment of their CHD

Design outcomes

Primary

Measure	Time frame
Since this is a pilot study, an aim is to identify appropriate primary and secondary outcome measures. The following measures will be tested: 1. Depression (HADS, 9-item Patient Health Questionnaire [PHQ-9]) 2. Coronary Heart Disease (Modified Rose Angina Questionnaire, Specific Activity Schedule) 3. Quality of Life (Euroqol 5D, 12-item Medical Outcomes Survey Short Form [SF-12]) 4. Adherence to medication (Adapted version of Morisky adherence questionnaire) 5. Life events (List of Threatening Events Questionnaire) 6. Social problems (Social Problems Questionnaire) 7. Health Service Utilisation (Client Service Receipt Inventory (CSRI)) 8. Illness Perceptions (Brief Illness Perceptions Questionnaire) 9. Participants' problem priorities (Psychlops) Assessments will be at 1, 6 and 12 months for all outcomes.	—

Measure

Time frame

Since this is a pilot study, an aim is to identify appropriate primary and secondary outcome measures. The following measures will be tested: 1. Depression (HADS, 9-item Patient Health Questionnaire [PHQ-9]) 2. Coronary Heart Disease (Modified Rose Angina Questionnaire, Specific Activity Schedule) 3. Quality of Life (Euroqol 5D, 12-item Medical Outcomes Survey Short Form [SF-12]) 4. Adherence to medication (Adapted version of Morisky adherence questionnaire) 5. Life events (List of Threatening Events Questionnaire) 6. Social problems (Social Problems Questionnaire) 7. Health Service Utilisation (Client Service Receipt Inventory (CSRI)) 8. Illness Perceptions (Brief Illness Perceptions Questionnaire) 9. Participants' problem priorities (Psychlops) Assessments will be at 1, 6 and 12 months for all outcomes.

—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed